KLSC aims to be the Middle East’s premiere Life Sciences Company achieving superior returns from innovative regional operations and global investments.
The Why?
The How?
The What?
LSA Subsectors
The Why?
The How?
The What? eCore is involved in:
Ecore subsectors Providing industrials and specialty chemical solutions for: (our sectors are Food industry/ Pharmaceutical Industry/ Home and Personal Care Industries/ Animal Feed industry/
The Why?
Innomedics aims to improve the efficiency of the healthcare services and encourage value based medicine by providing the most efficient and best value medical equipment and consumables
The How?
Innomedics delivers innovative technologies in health care sector through medical professionals, institutions and directly to the consumers via partnerships with local pharmacy and retail distributors
The What?
Innomedics is a regional distributor of medical technology in the GCC region that provides innovative medical solutions to healthcare service providers
Innomedics Business Units
Providing world class medical devices and consumables in the follow subsectors:
The Why? Clinart contributes to improve the ability for pharma, biotech and medical devices companies, academia and governments to host world-class clinical trials in the MENA region The How? Clinart provides quality services with a proven track record of successful trials in the MENA region (phase II-IV) since 2001 The What? Clinart MENA is a Contract Research Organization (CRO) headquartered in Dubai, Healthcare City offering a Full Service End-to-End solution that brings Clinical Research expertise to the Middle East region in line with local cultures and customs Clinart Subsectors Developing, Planning, Conducting and Managing clinical trials for:
The Why? NewBridge aims to improve the access for ‘big pharma’ companies, genomics and biologics manufacturers to the MENA region The How? NewBridge pharmaceuticals is a regional specialty company providing one-stop-solution to pharmaceuticals, biological, genomics and other innovative healthcare companies The What? NewBridge is the exclusive licensor of pharmaceutical products in: Oncology (Astral®, Aware®, Clasteon™, Halaven, M2PK®, Oncotype Dx®, Sancuso), Immunology (Cimzia®) , Nutrition(Celia®, Delicel®, RealDiet™, Taranis®), CNS Care (Ebenet® Diabase), Dermatology, (Glinconorm®, Pylera®), Metabolic Care (Neupro®, Vimpat®), Woman’s Health (Femmed®) New Bridge Subsectors Providing pharmaceutical commercialization of drugs in the following subsectors:
KLSC follows a similar investment strategy according to its parent company, NTEC, focusing on the following three pillars